Synchronous resection of primary colorectal tumor, liver metastases safe in some patients
the ONA take:
A recent study examined and compared patient outcomes associated with synchronous and sequential colorectal and liver resections in patients with stage IV colorectal cancer.
Generally, a combination therapy involving chemotherapy and surgical resection is used to treat colorectal cancer, but debate remains as to whether metastatic tumors should be surgically removed at the same time as the primary tumors (synchronously), as opposed to a sequential approach.
Researchers from the Mayo Clinic, led by David Nagorney, M.D., used a multi-institutional database to review a pool of 43,408 patients who underwent colorectal and liver resections for stage IV colorectal cancer. Individuals in the pool were assigned risk categories based on the extent of resection, as well as colorectal resection location.
The investigators compared outcomes within each category, comparing those that underwent synchronous colorectal and liver resections vs those who had these operations performed sequentially. The study goal was to evaluate the risk of the component operations and determine which combination of colon and liver procedures was safest.
Study data indicate that poor patient outcomes are tied more closely to the risk of individual procedures as opposed to timing. major complications are linked to the extent of resection required (liver resection or colorectal surgery).
The study data also indicate that synchronous resection of primary colorectal tumors and metastatic liver tumors is safe when minor liver resections are required.
Study results were published in Journal of Gastrointestinal Surgery.
Patient outcomes associated with synchronous and sequential colorectal and liver resections in patients with stage IV colorectal cancer.
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Risk of Second Cancers Increased in Hodgkin Lymphoma Survivors
- Directly Informing Patients of Breast Cancer Risk, Options Improves Follow-Up Screening
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Free Lung Cancer Screening Findings Support Continual Screenings in High-Risk Populations
- Parental Self-persuasion in Low-Income Groups Improves HPV Vaccination Rates
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Shared Decision-making Visits Improved Comfort With Lung Cancer Screening Decisions
- Temozolomide With Radiotherapy for Glioblastoma Provides Some Survival Benefit in Elderly
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|